Around the world, more than 100 coronavirus vaccine candidates are in development, as the need for a pandemic panacea grows ever more desperate. Here are updates from three promising experimental immunizations — two with Philadelphia roots. Thomas Jefferson University on Wednesday announced it has signed an exclusive deal with the global vaccine manufacturer Bharat Biotech…
Humboldt County Public Health confirmed four new cases of COVID-19, bringing to 61 the total number of Humboldt County residents confirmed to have the virus.One resident and one staff person at the Alder Bay Assisted Living Facility in Eureka tested positive for COVID-19 this weekend, one of which was reported in Saturday’s daily test results.…
Authorities reported three additional deaths due to the coronavirus Sunday in Tarrant County, including one man serving a sentence at a North Texas federal prison. The deaths reported by Tarrant County Public Health included a Kennedale woman in her 80s and a Bedford man in his 50s. Both had underlying health conditions. The Federal Bureau…
A sad and tired healthcare worker is seen by the Brooklyn Hospital Center in New York, United States on April 1, 2020.Tayfun Coskun | Anadolu Agency | Getty ImagesThe United States just had its deadliest day on record due to the coronavirus as states across the country begin to ease restrictions meant to curb the…
By Dan McKay and Dan Boyd / Journal Capitol Bureau Thursday, April 16th, 2020 at 4:35pm Albuquerque Fire Department paramedics and Albuquerque Ambulance personnel wear gloves and masks while responding to sick call in Northwest Albuquerque on Tuesday April 14, 2020. (Adolphe Pierre-Louis/Journal)SANTA FE — New Mexico health officials reported eight more deaths Thursday as…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f